Global Wealth Management Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-385
Closed -$19.8K 174
2023
Q4
$19.8K Buy
385
+108
+39% +$5.67K 0.01% 245
2023
Q3
$16.1K Hold
277
﹤0.01% 266
2023
Q2
$17.7K Buy
+277
New +$18.6K ﹤0.01% 255
2022
Q3
Sell
-277
Closed -$21K 179
2022
Q2
$21K Hold
277
0.01% 234
2022
Q1
$20K Hold
277
0.01% 256
2021
Q4
$17K Hold
277
0.01% 269
2021
Q3
$16K Hold
277
0.01% 276
2021
Q2
$19K Hold
277
0.01% 246
2021
Q1
$17K Sell
277
-35
-11% -$2.18K 0.01% 258
2020
Q4
$19K Buy
312
+35
+13% +$2.15K 0.01% 238
2020
Q3
$17K Sell
277
-1,800
-87% -$108K 0.01% 237
2020
Q2
$122K Sell
2,077
-196
-9% -$11.7K 0.05% 137
2020
Q1
$127K Hold
2,273
0.06% 116
2019
Q4
$146K Buy
2,273
+394
+21% +$22.6K 0.06% 122
2019
Q3
$95K Hold
1,879
0.04% 138
2019
Q2
$85K Sell
1,879
-175
-9% -$8.15K 0.04% 145
2019
Q1
$98K Sell
2,054
-2,659
-56% -$132K 0.05% 164
2018
Q4
$245K Buy
+4,713
New +$253K 0.14% 118

Other funds holding BMY

Global Wealth Management Investment Advisory's BMY Position: Q1 2024 in Review

Global Wealth Management Investment Advisory sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 385 shares — an estimated $19.8K sold.

Global Wealth Management Investment Advisory first reported a position in BMY in Q4 2018 and held it in 18 quarters. The position peaked at $245K in Q4 2018. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Global Wealth Management Investment Advisory reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 385 Bristol-Myers Squibb shares in Q1 2024, an estimated $19.8K.
  • Global Wealth Management Investment Advisory first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 18 quarters.
  • Global Wealth Management Investment Advisory's Bristol-Myers Squibb position peaked at $245K in Q4 2018.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.